ALX-0081

ALX-0081 · Ablynx (a Sanofi company)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALX-0081, covering 2023-04-04 to 2023-04-04. Get the full timeline:

Most recent: Clinical Trial Update: Comparative Study of ALX-0081 Versus GPIIb/IIIa Inhibitor in High Risk Percutaneous Coronary Intervention (PCI) Patients [Phase 2]

See pricing